Stock-PR Reporting
FREE Daily Stock Alerts From Stock-PR.com
________________________________________
Crown Equity Holdings Inc. (OTCPK:CRWE)
Crown Equity Holdings Inc. announced this month that its subsidiary company, Crown Tele Services Inc. (http://www.crownteleservices.com) is still moving forward after dissolving its joint venture with Communication Expert Corporation and will gradually start rolling out its internet based voice and video service IP-PBX solutions next year.
The cornerstone of Crown Tele Services Inc. strategy is to meet the highest standards when it comes to delivering VoIP (Voice over Internet Protocol) communication solutions specifically designed to meet the market needs.
Commenting on the venture, Kenneth Bosket, president said, "We are still excited with this opportunity to expand our footprint in this valuable market. The demand for internet-based voice and video services is growing exponentially and our new subsidiary Crown Tele Services Inc. has launched its new website and intends to emerge as a service provider of choice."
According to ABI Research, the latest global business VoIP services forecasts show that the value of the overall market, which includes VoIP integrated access, SIP trunking, hosted IP-PBX/IP Centrex and managed IP-PBX services, is set to double over the next five years, to exceed $20 billion by 2015.
Mitel Networks Corp. (Nasdaq:MITL) announced that Richard McBee has been appointed to its Board of Directors. Mitel previously announced that Mr. McBee has been appointed as Chief Executive Officer of the company. Mitel also announced that 515,175 of the stock options granted to Mr. McBee as a component of his employment compensation, and as described in the company's 8-K filing with the SEC on January 14, 2011, have been granted as an inducement material to his entering into employment with Mitel. These inducement options will vest on the same vesting schedule as options granted under the 2006 Equity Incentive Plan.
Mitel Networks Corporation provides integrated communications solutions primarily to the SME market in the United States and internationally. The company offers IP-based communications solutions that consist of a combination of IP telephony platforms, such as software, appliances, and desktop devices, and a suite of UCC applications that integrate voice, video, and data communications with business applications.
Local.com Corp. (Nasdaq:LOCM) announced the completion of its previously announced underwritten public offering of 4,600,000 shares of its common stock at a public offering price of $4.25 per share, including 600,000 shares of common stock sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. All of the shares were offered by Local.com. The net proceeds to the company from the sale of shares in the offering, after deducting underwriting discounts and commissions and anticipated expenses of the offering, are expected to be approximately $18.0 million. Canaccord Genuity acted as sole book-running manager for the offering.
Local.com Corporation provides local search services on the Internet. It operates Local.com, a local business directory site that provides information on approximately 14 million local businesses.
Cytori Therapeutics, Inc. (Nasdaq:CYTX) received approval from The Netherlands to initiate a pivotal European trial, named ADVANCE, to investigate adipose-derived stem and regenerative cells (ADRCs), processed by the Celution® One System, in the treatment of patients with acute heart attacks. This is the first country and trial-center approval for ADVANCE. Additional country and trial-center approvals are anticipated throughout Europe during the first half of 2011. One of the goals of the trial is to expand the Celution® System CE Mark to include acute heart attack claims and to provide economic data to justify its implementation and reimbursement.
Cytori Therapeutics, Inc. engages in the development, manufacture, and sale of medical technologies to enable the practice of regenerative medicine. Regenerative medicines focus on repairing or restoring lost or damaged tissue and cell function.
**************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
________________________________________
**********************************************************************
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.